ArticleSmall (Weinheim an der Bergstrasse, Germany)2026
Gold Nanoparticles-Embedded Mn/Zn-MOF with Enhanced Antioxidant Activities for Treating Atopic Dermatitis.
Article in Small (Weinheim an der Bergstrasse, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Atopic dermatitis (AD) is a skin disease characterized by impaired barrier function and immune dysregulation, in which oxidative stress imbalance plays a key pathogenic role. Current clinical therapies for AD treatment primarily target immune and inflammatory responses, but rarely address direct clearance of reactive oxygen species (ROS). To correct this imbalance, a multi-enzyme-mimetic nanocomposite, an Au@Mn/Zn bimetallic metal-organic framework (Au@Mn/Zn-MOF; AMZM) is constructed. Manganese sites in AMZM reversibly cycle among Mn(II/III/IV), thereby mimicking superoxide dismutase (SOD) and catalase (CAT) activities. Density functional theory calculations confirm that incorporated gold nanoparticles (AuNPs) optimize the electronic structure of Mn sites by stabilizing the key Mn(III) intermediate and lowering energy barriers, enabling efficient cascade scavenging of O
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.